English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

A novel parallel pathway for inositol sphingolipid synthesis in gut Bacteroidota

MPS-Authors
/persons/resource/persons272826

Heaver,  S       
Department Microbiome Science, Max Planck Institute for Biology Tübingen, Max Planck Society;

/persons/resource/persons275175

Vu,  DL
Mass Spectrometry, Max Planck Institute for Biology Tübingen, Max Planck Society;

/persons/resource/persons286403

Laugner,  S
Department Microbiome Science, Max Planck Institute for Biology Tübingen, Max Planck Society;

/persons/resource/persons270516

Ley,  R       
Department Microbiome Science, Max Planck Institute for Biology Tübingen, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Heaver, S., Vu, D., Laugner, S., & Ley, R. (2023). A novel parallel pathway for inositol sphingolipid synthesis in gut Bacteroidota. Poster presented at 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany.


Cite as: https://hdl.handle.net/21.11116/0000-000D-D486-C
Abstract
Inositol lipid production is phylogenetically restricted among bacteria but prevalent in host-associated Bacteroidetes. The inositol lipid metabolic pathway in the human symbiont Bacteroides thetaiotaomicron (BT) is similar to in mycobacteria and proceeds through a phosphatidylinositol-phosphate (PIP) intermediate. However, some Bacteroidota spp. lacking homology to the BT-like pathway for inositol lipid synthesis nevertheless produce inositol sphingolipids through a pathway we predicted to lack the PIP intermediate, instead generating CDP-inositol. Here, we characterize this alternative inositol lipid gene cluster via heterologous expression in BT and gene knockout in Phocaeicola dorei. We determine the activity of key enzymes in the gene cluster and characterize inositol lipid structural diversity in a panel of Bacteroidota, including novel inositol lipid structures present in abundant human symbionts. As inositol lipids are potent bioactive signaling molecules in humans, the inositol lipid contribution from gut- associated Bacteroidetes, via one of two metabolic pathways, offers future potential mechanisms for host-microbe interactions.